editor

“I feel happy,” the soft-spoken senior told Canada’s CTV News, speaking through a translator at a hospital in Portugal. “I’ve spent these years without hardship and without troubles.”

The U.S. Food and Drug Administration approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato. This is the first FDA-approved two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.

ECOM believes that one of the key elements to putting an end to the concentrated HIV epidemic in the CEECA region is the elimination of legal, social, economic, and gender barriers to accessing services.

Scientists have long tried to duplicate the procedure that led to the first long-term remission 12 years ago. With the so-called London patient, they seem to have succeeded.

The Global Fund Board has recently approved several multicountry grants, whose aim is to address priorities “deemed critical to fulfil the aims of the Global Fund 2017-2022 strategy,” and to address needs that are not being fulfilled by national (single country) allocations.

Initiative to Provide $17.6 Million to 30 U.S. Organizations to Elevate the Work of Community Groups and Provide Support Needed to Strengthen Care for People Aging with HIV

A historic moment for Belarus community of people living with HIV – on Dec 19, the most important amendment to article 157 of the Criminal Code of the Republic of Belarus was adopted. This amendment removes the responsibility of an HIV-positive person who has warned his partner about the infection, in the case of a recorded fact of HIV transmission.

The head of the UN agency focusing on AIDS says he’ll leave his post in June, an early departure announced a week after independent experts looking into sexual harassment at UNAIDS blasted its “defective leadership.”

A BHIVA members’ survey on U=U was undertaken in October 2018 which highlighted a need to ensure the U=U message is consistently integrated into clinical care, as recommended in the 2018 BHIVA standards of care for people living with HIV.

How one boy is tackling stereotypes in Kazakhstan.